Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-08-13
Summary
This study aims to evaluate the use of Next Generation Sequencing (NGS) to detect circulating tumor DNA in gastric cancer patients after gastrectomy
Conditions
- Gastric Cancer
- ctDNA
Interventions
- DIAGNOSTIC_TEST
-
ctDNA
The blood samples for ctDNA and other tumor markers will be first collected within 14 days before surgery, and then be tested after gastrectomy in scheduled interval
Sponsors & Collaborators
-
University Medical Center Ho Chi Minh City (UMC)
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-04
- Primary Completion
- 2026-12-30
- Completion
- 2026-12-30
Countries
- Vietnam
Study Locations
More Related Trials
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
Early Detection and Post-operative Monitoring of Gastric Cancer
NCT06232395 ·Status: RECRUITING
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05991947 ·Status: RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
NCT05224596 ·Status: UNKNOWN
-
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
NCT06023121 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
NCT05227261 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN
-
Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
NCT06308510 ·Status: RECRUITING
-
Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer
NCT03076567 ·Status: COMPLETED
-
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 ·Status: RECRUITING
-
Gastric Cancer Marker Detection and Its Kit Development
NCT05010863 ·Status: RECRUITING
-
Microscopy Imaging of Whole-mount Stained Human Tissues
NCT05689112 ·Status: RECRUITING
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer
NCT05397548 ·Status: UNKNOWN
-
Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients
NCT04821895 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
NCT00963092 ·Status: UNKNOWN
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING